Efficacy of sacituzumab govitecan based regimen in triple-negative breast cancer: A systematic review.

被引：0
|
作者：
Khalid, Farhan
Kashyap, Richi
Singh, Vinit
Tayyeb, Muhammad
Jaan, Ali
Mohan, Gaurav
Meghal, Trishala
机构：
[1] Monmouth Med Ctr, Dept Internal Med, Long Branch, NJ USA
[2] North Alabama Med Ctr, Dept Internal Med, Florence, AL USA
[3] Rochester Gen Hosp, Dept Internal Med, Rochester, NY USA
[4] Monmouth Med Ctr, Dept Med, Sect Hematol, Long Branch, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13068
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Exposure-response analyses of sacituzumab govitecan (SG) efficacy and safety in patients (pts) with metastatic triple-negative breast cancer (mTNBC).
    Singh, Indrajeet
    Sathe, Abhishek G.
    Singh, Pratap
    Diderichsen, Paul M.
    Fauchet, Floris
    Maringwa, John
    Pierrillas, Philippe
    Phan, See-Chun
    Girish, Sandhya
    Othman, Ahmed A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases
    De Moura, Alexandre
    Loirat, Delphine
    Vaillant, Sarah
    Korbi, Sinen
    Kiavue, Nicolas
    Roufai, Diana Bello
    Escalup, Laurence
    Desmaris, Romain
    Vaflard, Pauline
    Cottu, Paul
    Pierga, Jean-Yves
    Bidard, Francois-Clement
    Cabel, Luc
    Acramel, Alexandre
    BREAST CANCER, 2024, 31 (04) : 572 - 580
  • [43] Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer
    Rugo, Hope S.
    Tolaney, Sara M.
    Loirat, Delphine
    Punie, Kevin
    Bardia, Aditya
    Hurvitz, Sara A.
    O'Shaughnessy, Joyce
    Cortes, Javier
    Dieras, Veronique
    Carey, Lisa A.
    Gianni, Luca
    Piccart, Martine J.
    Loibl, Sibylle
    Goldenberg, David M.
    Hong, Quan
    Olivo, Martin
    Itri, Loretta M.
    Kalinsky, Kevin
    NPJ BREAST CANCER, 2022, 8 (01)
  • [44] Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer Comment
    Rozenblit, Mariya
    Lustberg, Maryam B.
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (07)
  • [45] VIC-1911, a selective Aurora kinase A inhibitor, synergizes with sacituzumab govitecan in triple-negative breast cancer
    Lee, Jangsoon
    Gi, YoungJin
    Myers, Thomas
    Paradise, Linda
    Tripathy, Debu
    Ueno, Naoto T.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [46] OptimICE-RD: sacituzumab govitecan plus pembrolizumab vs pembrolizumab (± capecitabine) for residual triple-negative breast cancer
    Tolaney, Sara M.
    DeMichele, Angela
    Takano, Toshimi
    Rugo, Hope S.
    Perou, Charles
    Lynce, Filipa
    Parsons, Heather Anne
    Santa-Maria, Cesar Augusto
    Rocque, Gabrielle Betty
    Yao, Wenliang
    Sun, Shawn W.
    Mocci, Simonetta
    Partridge, Ann H.
    Carey, Lisa A.
    FUTURE ONCOLOGY, 2024, 20 (31) : 2343 - 2355
  • [47] Sacituzumab govitecan in Chinese patients with metastatic triple-negative breast cancer who received at least two prior treatments
    Xu, B.
    Ma, F.
    Wang, S.
    Tong, Z.
    Li, W.
    Wu, X.
    Wang, X.
    Sun, T.
    Pan, Y.
    Yao, H.
    Wang, X.
    Luo, T.
    Yang, J.
    Zeng, X.
    Zhao, W.
    Cong, X. J.
    Chen, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S650 - S650
  • [48] Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial
    Spring, L. M.
    Tolaney, S. M.
    Fell, G.
    Bossuyt, V.
    Abelman, R. O.
    Wu, B.
    Maheswaran, S.
    Trippa, L.
    Comander, A.
    Mulvey, T.
    McLaughlin, S.
    Ryan, P.
    Ryan, L.
    Abraham, E.
    Rosenstock, A.
    Garrido-Castro, A. C.
    Lynce, F.
    Moy, B.
    Isakoff, S. J.
    Tung, N.
    Mittendorf, E. A.
    Ellisen, L. W.
    Bardia, A.
    ANNALS OF ONCOLOGY, 2024, 35 (03) : 293 - 301
  • [49] Metabolomics and triple-negative breast cancer: A systematic review
    Arenas, Meritxell
    Fargas-Saladie, Maria
    Moreno-Sole, Marta
    Moyano-Femenia, Lucia
    Jimenez-Franco, Andrea
    Canela-Capdevila, Marta
    Castane, Helena
    Martinez-Navidad, Cristian
    Camps, Jordi
    Joven, Jorge
    HELIYON, 2024, 10 (01)
  • [50] Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review
    Hosseini, Mina
    Seyedpour, Simin
    Khodaei, Behzad
    Loghman, Amir-Hossein
    Seyedpour, Nasrin
    Yazdi, Mohammad-Hossein
    Rezaei, Nima
    VACCINES, 2023, 11 (01)
12345